August 27, 2016 7:21 AM ET

Biotechnology

Company Overview of Neogenix Oncology, Inc.

Executive Profile

Barry Gause M.D.

Director, Member of Audit Committee and Member of Compensation Committee, Neogenix Oncology, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
65--

Background

Dr. Barry Gause, M.D., has been Chief Medical Officer and Director of the Clinical Research Directorate at SAIC-Frederick, Inc. since September 2008. Prior to SAIC-Frederick, Dr. Gause served for over twenty years at the National Cancer Institute. He has been Director of Neogenix Oncology, Inc. since 2009. Dr. Gause received his Doctor of Medicine degree from Michigan State University's College of Human Medicine in 1976. He trained in Internal Medicine and Pediatrics ...

Corporate Headquarters

445 Northern Boulevard
Great Neck, New York 11021

United States

Phone: 516-482-1200
Fax: 516-482-3848

Board Members Memberships

2009-Present
Director, Member of Audit Committee and Member of Compensation Committee

Education

Unknown/Other Education
Emory University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Neogenix Oncology, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.